Stress cardiomyopathy as a cardiovascular manifestation of COVID-19

Authors

  • Khaled M Abdullah UCSF Fresno, 155 N Fresno St, Fresno, CA 93701, United States
  • Mohamad Bakir Alfaisal University, College of Medicine, Riyadh, Saudi Arabia.
  • Danielle Greenberg UCSF Fresno, 155 N Fresno St, Fresno, CA 93701, United States
  • Eyad Almasri UCSF Fresno, 155 N Fresno St, Fresno, CA 93701, United States

DOI:

https://doi.org/10.21542/gcsp.2023.29

Abstract

Patients with coronavirus disease 2019 (COVID-19) may present with a broad spectrum of clinical manifestations, affecting several organ systems. Commonly reported cardiac manifestations include myocardial injury, heart failure (HF), cardiogenic shock, and arrhythmias. Stress (takotsubo) cardiomyopathy, which is characterized by apical ballooning of the heart leading to acute left ventricular dysfunction, is rarely seen in patients with COVID-19. We present a case of COVID-19-associated stress cardiomyopathy in a female in her sixties.

Downloads

Additional Files

Published

2023-09-10

Issue

Section

Images in cardiology